Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.39 - $2.27 $13,571 - $22,164
9,764 New
9,764 $14,000
Q4 2023

Feb 09, 2024

BUY
$1.52 - $2.04 $6,865 - $9,214
4,517 New
4,517 $7,000
Q2 2023

Aug 11, 2023

BUY
$1.56 - $2.38 $3,294 - $5,026
2,112 Added 211.2%
3,112 $6,000
Q4 2022

Feb 08, 2023

SELL
$1.18 - $2.32 $4,187 - $8,233
-3,549 Reduced 78.02%
1,000 $1,000
Q3 2022

Nov 10, 2022

BUY
$1.65 - $3.42 $7,393 - $15,325
4,481 Added 6589.71%
4,549 $9,000
Q2 2022

Aug 10, 2022

SELL
$1.85 - $3.22 $4,118 - $7,167
-2,226 Reduced 97.04%
68 $0
Q1 2022

May 16, 2022

BUY
$3.01 - $4.81 $6,904 - $11,034
2,294 New
2,294 $7,000
Q3 2021

Nov 15, 2021

SELL
$3.3 - $6.49 $5,534 - $10,883
-1,677 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$3.35 - $5.67 $25,855 - $43,761
-7,718 Reduced 82.15%
1,677 $6,000
Q1 2021

May 12, 2021

BUY
$4.75 - $6.87 $13,152 - $19,023
2,769 Added 41.79%
9,395 $52,000
Q4 2020

Feb 11, 2021

BUY
$5.35 - $7.77 $32,281 - $46,884
6,034 Added 1019.26%
6,626 $36,000
Q3 2020

Nov 12, 2020

SELL
$7.22 - $9.11 $39,962 - $50,423
-5,535 Reduced 90.34%
592 $4,000
Q2 2020

Jul 31, 2020

BUY
$4.93 - $10.26 $15,460 - $32,175
3,136 Added 104.85%
6,127 $53,000
Q1 2020

May 01, 2020

BUY
$2.58 - $6.6 $7,716 - $19,740
2,991 New
2,991 $16,000
Q4 2019

Feb 14, 2020

SELL
$5.02 - $6.66 $13,423 - $17,808
-2,674 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$4.98 - $6.7 $102,822 - $138,334
-20,647 Reduced 88.53%
2,674 $16,000
Q2 2019

Aug 14, 2019

BUY
$3.15 - $6.95 $73,461 - $162,080
23,321 New
23,321 $146,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $49.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.